Vetter Pharma-Fertigung GmbH & Co. KG

Planning for success.

The period from preclinical through phase III is sometimes unpredictable for new molecules. With Vetter, you have a partner you can trust to support you throughout drug product development, clinical manufacturing and regulatory approval. We are ready to provide cli...

Quality across the supply chain 

Commercial manufacturing of pharmaceutical and biotech drugs is a complex business today, requiring close integration of sophisticated resources and technologies to deliver top quality and solve supply chain challenges. Vetter’s decades of experience as...

Packaging matters.

At every stage of your product’s life cycle, there are many packaging questions to consider –from ensuring material compatibility to meeting the growing demand for patient-friendly systems.
Vetter can help you identify and develop the right packaging strategies f...

As a leading global CDMO, we offer comprehensive fill-and-finish services from clinical development to your product's market launch and beyond.

Vetter again demonstrates industry leadership in sustainability initiatives

As experienced partner in injectable manufacturing, we support you every step of the way, guiding your product through development, regulatory approval, launch, market supply and life cycle management, accelerating your ability to bring new drugs to market

Pharma service provider further expands offerings for clinical development and manufacturing

We look at your project from every angle to help you find answers that work – answers that support your goals for quality, reliability, innovation, safety, and efficiency. When you partner with us, we integrate with your team to design and implement a personalized plan for success in a shifting global marketplace.

CDMO honored as an exceptionally managed company

Delivering your product’s potential

CDMO joins United Nations Global Compact

Delivering results across the production chain

The CDMO Leadership Awards is an annual event now in its 12th year. In determining the award recipients, Life Science Leader teams up with (ISR) which conducted the research. For the 2023 award, more than 72 contract manufacturers were assessed by 23 performance metrics in ISR’s annual Contract Manufacturing Quality Benchmarking survey. Participants were recruited from pharma and biotech companies of all sizes and screened for decision-making influence related to working with contract manufacturing partners. Respondents only evaluate those companies with which they have worked on an outsourced project within the past 18 months. Through this level of qualification, survey responses are based on actual involvement with contract manufacturers and clear experiential data. 

From clinical development to commercial production

Vetter (Ravensbury, Germany), the aseptic filling and packaging CDMO has signed up to the UN Global Compact Network. 

Supporting your compounds success

With the increasing drug development for novel therapeutics, a growing number of pharmaceutical and biotech companies are seeking clinical manufacturing partners to help meet the demand for complex fill-and-finish solutions. And, while the stages of early drug development are challenging, Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO) is committed to addressing this challenge by offering comprehensive expert manufacturing services for clinical trials and supporting their customer products' path to commercialization. A testament to this commitment is evidenced by the success of its Skokie facility which has already contributed to bringing five new customer products to market since it began full operations in 2011, with another four expected to launch in the next months. 

Build them together with Vetter.

Succeeding in today’s global pharmaceutical and biotech markets requires flexible thinking and precise manufacturing. No matter what phase of development your injectable product is in, we have solutions that can open new doors, shorten lead times, and solve complex challenges. At Vetter, we look at your project from every angle to help you find answers that work – answers that support your goals for quality, reliability, innovation, safety,and efficiency. When you partner with us, we integrate with your team to design and implement a personalized plan for success in a shifting global marketplace.

Vetter, a globally leading contract development and manufacturing organization (CDMO), achieved gold status in the renowned, independent EcoVadis sustainability ranking. With 72 points out of a maximum of 100, the pharmaceutical service provider significantly increased its score compared to the last evaluation and is now among the top five percent of all participating companies in the industry.

We’re a global expert in aseptic filling and packaging of injectable drug products – learn more about us.

Vetter, a globally leading contract development and manufacturing organization (CDMO), announced the commissioning of a new warehouse designed to help meet increasing customer market supply demands. 

Get your product to the clinic with confidence

The shift from preclinical to clinical development is a critical step in the development of your drug product.


During this transition, you not only have to significantly upscale production of your product, but also make many strategic decisions that will lay important groundwork for your regulatory submission, commercial production of your product, and many other key components of your products life-cycle.


This eBook will help you build a plan that not only streamlines your products path to the clinic but also sets you up for long-term development and market success - starting with a proven 6-step process for filling your critical clinical batch.

Vetter, a globally leading contract development and manufacturing organization (CDMO), has in place a comprehensive sustainability strategy that has made it a pioneer in this energy-intensive industry. 

We offer a wide range of packaging services and injectable delivery systems that can be tailored to your product’s specific needs and optimize end-user convenience.

Pharmaceutical service provider integrates sustainability goals into its corporate strategy
 

This innovative concept is based on the central idea of fully automated decontamination of the entire cleanroom, including RABS, using hydrogen peroxide (H2O2). V-CRT®️ is a two-barrier system that minimizes the risk of contamination and offers a number of advantages over existing concepts.

Opportunities for contract development and manufacturing organisations (CDMOs) in China continue to grow but many questions remain over what the future of the sector will look like in the world's second largest pharmaceutical market.

Comprehensive support for your injectable | Aseptic fill finish services at Vetter.

Vetter wins the 2022 CMO Leadership Awards | Statement Sr. Vice President Carsten Press

Market developments and multifaced impacts (Interview with Oskar Gold)

The increasing demand for the manufacturing of highly complex biologics has driven many biotech and pharma companies to seek alliances with CDMOs. A qualified CDMO can help to understand business priorities, develop strategies to save time and costs, and provide regulatory guidance. This, in turn, means that CDMOs must have the right approach in place to fulfil high-quality requirements and have the right manufacturing technologies and capabilities in place. The complexity of CDMOs’ work will increase with new markets, demographic changes, and new demands in the clinical production of pharmaceuticals. This podcast was originally aired as part of the CPHI Festival of Pharma.